FDA Advisers Unanimously Back J&J Hepatitis C DrugAn experimental hepatitis C drug from Johnson & Johnson has won unanimous support from government advisers who say the medication should be approved to treat patients infected with the liver-destroying virus.

More From CBS DC

D.C. Lottery Live
Follow and Like Us

Listen Live